Brief: Cosmo And Adalvo Sign License And Supply Agreement For Rifamycin Sv Mmx® 200Mg In Europe, APAC, MENA And Latam Regions

Cosmo NV

04/09/2023 06:18

Sept 4 (Reuters) - Cosmo Pharmaceuticals Nv  COPN.S :
    * COSMO AND ADALVO SIGN LICENSE AND SUPPLY AGREEMENT FOR
RIFAMYCIN
SV MMX® 200MG IN EUROPE, APAC, MENA AND LATAM REGIONS
    * ADALVO WILL RECEIVE FROM COSMO EXCLUSIVE RIGHT TO DEVELOP,
REGISTER AND COMMERCIALIZE RIFAMYCIN SV MMX® 200MG
    * COSMO WILL RECEIVE AN UPFRONT PAYMENT IN ADDITION TO
CUSTOMARY
DOUBLE-DIGIT ROYALTIES ON NET SALES.

Source text for Eikon:  ID:nEQb0GTh5a 
Further company coverage:  COPN.S 

 ((Reuters.Briefs@thomsonreuters.com;))